CNS
![](https://www.calyx.ai/wp-content/uploads/2024/06/Improving-Neuro-Psychiatric-Trial-Blog-Header-600x300.jpg)
![](https://www.calyx.ai/wp-content/uploads/2024/06/Improving-Neuro-Psychiatric-Trial-Blog-Header-600x300.jpg)
Improving Neuro-Psychiatric Trial Outcomes through fMRI: An Interview with Emily Stern, MD, CEO and Co-founder, Ceretype Neuromedicine
![](https://www.calyx.ai/wp-content/uploads/2024/03/RANO-2.0-CNS-Calyx-Image-600x300.jpg)
Implementing RANO 2.0 in Glioblastoma Clinical Trials
![](https://www.calyx.ai/wp-content/uploads/2022/10/18OCT2022-mi-advanced-ms-casestudy-header_v1-600x300.jpg)
Advanced Neuroimaging in Multiple Sclerosis
![](https://www.calyx.ai/wp-content/uploads/2022/10/18OCT2022-mi-ms-casestudy-header-v1-600x300.jpg)
Neuroimaging in Multiple Sclerosis
![](https://www.calyx.ai/wp-content/uploads/2021/01/Macro_Filter_iStock-157444120-600x300.jpg)